Factor V haemostatic diathesis impairing thrombin activation, membrane binding and circulating antigen level due to a novel compound heterozygous mutation, Leu1821Ser and Gly2192Cys
These findings are consistent with the observed phenotype, highlighting the importance of understanding FV biochemical function to rationalize clinical bleeding severity when the circulating antigen level is discordant.
Authors
- Ross T. A. MacGillivray
- Kimberley Talbot
- Shannon Jackson
- Edward L.G. Pryzdial (ORCID: https://orcid.org/0000-0001-9170-7586)
- Jina Song (ORCID: https://orcid.org/0000-0002-9931-1129)
- J. Perrier
Institutions
- University of British Columbia Hospital (CA)
- Providence Health Care (CA)
- University of British Columbia (CA)
- St. Paul's Hospital (CA)
- Canadian Blood Services (CA)
Publication Details
- Journal
- Haemophilia
- Published
- 2024-08-08
- DOI
- https://doi.org/10.1111/hae.15087
- Primary Topic
- Blood Coagulation and Thrombosis Mechanisms
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Heart and Stroke Foundation of Canada
- Canadian Blood Services
- Centre for Blood Research, University of British Columbia